New injection shows promise for reducing bulging eyes in thyroid condition

NCT ID NCT05517421

Completed Disease control Sponsor: Immunovant Sciences GmbH Source: ClinicalTrials.gov ↗

Summary

This completed Phase 3 trial tested whether weekly injections of an experimental drug called batoclimab could reduce eye bulging (proptosis) and inflammation in people with active Thyroid Eye Disease. The study involved 114 adults who received either the drug or a placebo for 24 weeks. The main goal was to see if the drug was better than a placebo at reducing eye protrusion by a specific amount.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Site Number - 1500

Roanoke, Virginia, 24018, United States
Site Number - 1501

Aurora, Colorado, 80045, United States
Site Number - 1502

Los Angeles, California, 90025, United States
Site Number - 1504

Miami, Florida, 33136, United States
Site Number - 1505

Los Angeles, California, 90033, United States
Site Number - 1506

Boston, Massachusetts, 02130, United States
Site Number - 1507

Portland, Oregon, 97232, United States
Site Number - 1508

Houston, Texas, 77030, United States
Site Number - 1509

Madison, Wisconsin, 53705, United States
Site Number - 1530

Chapel Hill, North Carolina, 27517, United States
Site Number - 1531

Torrance, California, 90505, United States
Site Number - 1532

Los Angeles, California, 90255, United States
Site Number - 1534

Chicago, Illinois, 60610, United States
Site Number - 1535

Baltimore, Maryland, 21231, United States
Site Number - 1536

West Palm Beach, Florida, 33401, United States
Site Number - 1537

San Diego, California, 92108, United States
Site Number - 1538

Port Charlotte, Florida, 33952, United States
Site Number - 1539

Carlsbad, California, 92011, United States
Site Number - 1540

Las Vegas, Nevada, 89184, United States
Site Number - 1542

Tampa, Florida, 33603, United States
Site Number - 1544

Longmont, Colorado, 80503, United States
Site Number - 1545

Iowa City, Iowa, 52242, United States
Site Number - 1547

Newark, Delaware, 19713, United States
Site Number - 1550

Columbus, Ohio, 43215, United States
Site Number - 1551

Dallas, Texas, 75231, United States
Site Number - 1554

Stockbridge, Georgia, 30281, United States
Site Number - 1556

Warwick, Rhode Island, 02886, United States
Site Number - 1557

Beverly Hills, California, 90210, United States
Site Number - 1558

Mesquite, Texas, 75149, United States
Site Number - 2500

Ottawa, Ontario, K1H 8L6, Canada
Site Number - 2501

Montreal, Quebec, H1T 2M4, Canada
Site Number - 2502

Edmonton, Alberta, T6G 2E1, Canada
Site Number - 3100

Warsaw, 02-097, Poland
Site Number - 3101

Krakow, 30-688, Poland
Site Number - 3102

Lublin, 20-562, Poland
Site Number - 3103

Katowice, 40-514, Poland
Site Number - 3104

Lublin, 20-171, Poland
Site Number - 3105

Lublin, 60-354, Poland
Site Number - 3106

Olsztyn, 10-561, Poland
Site Number - 3107

Gliwice, 44-102, Poland
Site Number - 3450

Tbilisi, 0159, Georgia
Site Number - 3451

Tbilisi, 0159, Georgia
Site Number - 3452

Tbilisi, 0101, Georgia
Site Number - 3453

Tbilisi, 0186, Georgia
Site Number - 3454

Tbilisi, 0114, Georgia
Site Number - 3455

Tbilisi, 0114, Georgia
Site Number - 4760

Ramat Gan, 5265601, Israel
Site Number - 4761

Jerusalem, 91120, Israel
Site Number - 4762

Petah Tikva, 4941492, Israel
Site Number - 4763

Nahariya, 2210000, Israel
Site Number - 4764

Afula, 1834111, Israel
Site Number - 6200

Pisa, 56100, Italy
Site Number - 6201

Pisa, 56124, Italy
Site Number - 6202

Roma, 00189, Italy
Site Number - 6203

Milan, 20149, Italy
Site Number - 6204

Milan, 20122, Italy
Site Number - 6205

Napoli, 80131, Italy
Site Number - 6206

Bologna, 40138, Italy
Site Number - 6207

Catania, CAP95125, Italy
Site Number - 6208

Rome, 00161, Italy
Site Number - 6209

Palermo, 90127, Italy
Site Number - 6604

Mainz, Rhineland-Palatinate, 55131, Germany
Site Number - 6608

Frankfurt am Main, Hesse, 60318, Germany
Site Number - 6609

Tübingen, Baden - Wuttemberg, 72076, Germany
Site Number - 6610

Leipzig, Saxony, 04103, Germany
Site Number - 6611

Schwerin, 19049, Germany
Site Number - 7300

Manchester, M139WL, United Kingdom
Site Number - 7302

Newcastle upon Tyne, NE1 3BZ, United Kingdom
Site Number - 7303

London, EC1V 2PD, United Kingdom
Site Number - 7305

Guildford, GU2 7XX, United Kingdom
Site Number - 7308

Sheffield, S102SB, United Kingdom
Site Number - 7309

Leicester, LE15WW, United Kingdom
Site Number - 7310

Hull, HU6 7RX, United Kingdom
Site Number - 7311

London, SE17EH, United Kingdom
Site Number - 7312

London, W1T 6AH, United Kingdom
Site Number - 7313

London, W1T 7HA, United Kingdom
Site Number - 7401

Fukuoka, 812-0011, Japan
Site Number - 7402

Kitakyushu, 807-8556, Japan
Site Number - 7403

Hyōgo, 663-8501, Japan
Site Number - 7404

Tottori, 683-8504, Japan
Site Number - 7406

Nagoya, 467-8602, Japan
Site Number - 7407

Nagasaki, 852-8501, Japan
Site Number - 7408

Osaka, 545-0051, Japan
Site Number - 7409

Tokyo, 173-8610, Japan
Site Number - 7410

Kanagawa, 230-8765, Japan
Site Number - 7411

Ibaraki, 305-8576, Japan
Site Number - 7412

Nankoku, 783-0043, Japan
Site Number - 7413

Yamaguchi, 754-0002, Japan
Site Number - 7414

Miyazaki, 889-1692, Japan
Site Number - 7415

Maebashi, Gunma, 371-8511, Japan
Site Number - 7416

Kumamoto, 860-8556, Japan
Site Number - 7417

Kobe, 657-0068, Japan
Site Number- 7418

Hokkaido, Sapporo, 060-8648, Japan

Conditions

Explore the condition pages connected to this study.

THYROID EYE DISEASE